Name
AccurKardia
Company Description
AccurKardia transforms ECG data into a more powerful diagnostic tool and broad biomarker. FDA-cleared AccurECG automates analysis from Holter, patches, and MCTs. AK+ Guard (FDA BDD and TAP) detects hyperkalemia from Lead I ECGs. AK-AVS (FDA BDD) detects aortic stenosis via 12-lead ECGs. Completed MedTech Innovator’s 2024 Cohort and AHA’s Heart and Brain Health Accelerator within MTI.
Website
Product Categories
Technology - Computer Hardware, Software and/or Patient Management Tools with Medical Applications, Artificial Intelligence (AI)
ACC.25 Learning Pathways? (select all that apply)
Electrophysiology, Valvular Heart Disease
First-Time Exhibitor?
Yes
Address
101 Avenue of the Americas
Suite 931
New York, 10013
Suite 931
New York, 10013